Fubio completedISO 9001
Since obtaining the ISO 9001 quality system management certificate for the first time in 2021, Fubio Biotechnology has always adhered to the principle of high standards and strict requirements. Under the strict supervision and audit of a professional expert group, we have successfully completed the ISO 9001 certification renewal work. This not only marks our achievement of international advanced standards in quality management and service level, but also ensures that we can continuously and stably provide customers with technical services that meet expectations and satisfaction.
(First meeting review site map)
The successful renewal of ISO 9001 certification not only reflects the company's high standards and strict requirements for quality management in product development and production, but also marks a crucial step towards standardization, normalization, and internationalization in the construction of our quality management system. In the future, Fubio Biotechnology will continue to tirelessly strive to improve its quality management level, closely focus on customer needs, adhere to product quality as the lifeline of the enterprise, and be committed to providing customers with more excellent and reliable products and services.
关于ISO 9001
ISO 9001 is a quality management system standard developed by the International Organization for Standardization (ISO), which provides a framework for organizations to ensure that their products and services continue to meet the requirements of customers and applicable laws and regulations. ISO 9001 certification demonstrates that an organization is able to consistently provide products and services that meet customer and applicable regulatory requirements, which helps to enhance the organization's quality reputation and market competitiveness.
About us于我们
Fubio (Suzhou) Biomedical Technology Co., Ltd., established in 2017, is a platform based company dedicated to the research and clinical translation of gene delivery vectors. We are committed to providing customers with one-stop virus products and services from basic research to clinical translation. The company has the most comprehensive and diverse virus vector library in China, with a product pipeline covering more than 30 types of virus vectors such as lentivirus, adenovirus, adeno-associated virus (AAV), oncolytic virus, etc; As of 2023, we have established partnerships with over 500 institutions, serving multiple fields such as life sciences, in vitro diagnostics (IVD), vaccine development, and cellular gene therapy (CGT), assisting in project research for scientific and industrial clients, and accelerating the transformation of clinical products.us
Ordering
Official Account
Video Account
